Aralez Bio
Berkeley, US · 8 known investors
Aralez Bio uses an enzyme-based (biocatalysis) platform to produce noncanonical amino acids and protected amino acid building blocks for peptide therapeutic discovery and manufacturing teams. It positions its enzymatic process as a greener alternative to traditional amino acid synthesis and manufactures at scale in Berkeley, California.
BiotechCleantechNew Materials
Investors · 8
.jpeg){kind=logo}
In the news
Frequently asked questions
- What does Aralez Bio do?
- Aralez Bio uses an enzyme-based (biocatalysis) platform to produce noncanonical amino acids and protected amino acid building blocks for peptide therapeutic discovery and manufacturing teams. It positions its enzymatic process as a greener alternative to traditional amino acid synthesis and manufactures at scale in Berkeley, California.
- Who are Aralez Bio's investors?
- Aralez Bio's investors include Astia, Fifty Years, FREEFLOW, Good Growth Capital, ISV, Juniper, Paladin Capital Group, Spero Ventures.
- Where is Aralez Bio headquartered?
- Aralez Bio is headquartered in Berkeley, US.